| Hartselle Family Practice | |
|
1211 Highway 31 Nw Hartselle AL 35640-4420 | |
| (256) 773-6017 | |
| (256) 773-7834 |
| Full Name | Hartselle Family Practice |
|---|---|
| Speciality | Family Medicine |
| Location | 1211 Highway 31 Nw, Hartselle, Alabama |
| Authorized Official Name and Position | Darcell Robinson (DIRECTOR OF PHYSICIAN NETWORK) |
| Authorized Official Contact | 2563412802 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Hartselle Family Practice 1211 Highway 31 Nw Hartselle AL 35640-4420 Ph: (256) 773-6017 | Hartselle Family Practice 1211 Highway 31 Nw Hartselle AL 35640-4420 Ph: (256) 773-6017 |
| NPI Number | 1629482302 |
|---|---|
| Provider Enumeration Date | 06/20/2014 |
| Last Update Date | 06/20/2014 |
| Medicare PECOS PAC ID | 1254654866 |
|---|---|
| Medicare Enrollment ID | O20150106000324 |
News Archive
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced that, on January 7, 2010, it received notice from the Nasdaq Stock Market (Nasdaq) confirming that the Company has regained compliance with the $1.00 minimum closing bid price requirement for continued listing on The Nasdaq Capital Market under Listing Rule 5450(a)(1).
Newly published research by Harvard Medical School and the RAND Corporation reveals a dramatic growth in the use of telemedicine for the diagnosis and treatment of mental health disorders in rural areas, but strikingly uneven distribution of services across states.
A type of antibiotic that can cause hearing loss in people has been found to paradoxically protect the ears when given in extended low doses in very young mice.
Dasabuvir (trade name Exviera) and the fixed-dose drug combination ombitasvir/paritaprevir/ritonavir (trade name Viekirax) have been available since January 2015 for the treatment of adults with chronic hepatitis C infection. The German Institute for Quality and Efficiency in Health Care had examined their added benefit in a dossier assessment completed in April 2015.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629482302 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Amit V Vora |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1336121458 PECOS PAC ID: 7719078609 Enrollment ID: I20070807000437 |
News Archive
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced that, on January 7, 2010, it received notice from the Nasdaq Stock Market (Nasdaq) confirming that the Company has regained compliance with the $1.00 minimum closing bid price requirement for continued listing on The Nasdaq Capital Market under Listing Rule 5450(a)(1).
Newly published research by Harvard Medical School and the RAND Corporation reveals a dramatic growth in the use of telemedicine for the diagnosis and treatment of mental health disorders in rural areas, but strikingly uneven distribution of services across states.
A type of antibiotic that can cause hearing loss in people has been found to paradoxically protect the ears when given in extended low doses in very young mice.
Dasabuvir (trade name Exviera) and the fixed-dose drug combination ombitasvir/paritaprevir/ritonavir (trade name Viekirax) have been available since January 2015 for the treatment of adults with chronic hepatitis C infection. The German Institute for Quality and Efficiency in Health Care had examined their added benefit in a dossier assessment completed in April 2015.
› Verified 5 days ago
News Archive
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced that, on January 7, 2010, it received notice from the Nasdaq Stock Market (Nasdaq) confirming that the Company has regained compliance with the $1.00 minimum closing bid price requirement for continued listing on The Nasdaq Capital Market under Listing Rule 5450(a)(1).
Newly published research by Harvard Medical School and the RAND Corporation reveals a dramatic growth in the use of telemedicine for the diagnosis and treatment of mental health disorders in rural areas, but strikingly uneven distribution of services across states.
A type of antibiotic that can cause hearing loss in people has been found to paradoxically protect the ears when given in extended low doses in very young mice.
Dasabuvir (trade name Exviera) and the fixed-dose drug combination ombitasvir/paritaprevir/ritonavir (trade name Viekirax) have been available since January 2015 for the treatment of adults with chronic hepatitis C infection. The German Institute for Quality and Efficiency in Health Care had examined their added benefit in a dossier assessment completed in April 2015.
› Verified 5 days ago
Lindsay Smith, Md Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1211 Highway 31 Nw, Hartselle, AL 35640 Phone: 256-773-6017 | |
Gladstone Primary Care Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 301 Pine St Nw Ste A, Hartselle, AL 35640 Phone: 256-773-6017 Fax: 256-773-7834 | |
Community Urgent Care Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1635 Highway 31 Nw, Hartselle, AL 35640 Phone: 256-773-0110 | |
Andrew S. Dukes M.d. P.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 310 Pine St Nw, Suite B, Hartselle, AL 35640 Phone: 256-773-2952 Fax: 256-751-0737 | |
Valley Family Medicine Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 301 Pine St Nw, Suite A, Hartselle, AL 35640 Phone: 256-773-5469 | |
Bsnr Llc. Hartselle Valley Family Medical Center Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 301 Pine St Nw Ste B, Hartselle, AL 35640 Phone: 256-773-5469 Fax: 256-773-5425 | |
Sterling Hospitalists Of Alabama, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 201 Pine St Nw, Hartselle, AL 35640 Phone: 256-751-3000 |